Inc.;VentiRx Pharmaceuticals;Array Biopharma, Inc.;VentiRx Pharmaceuticals, Inc.
发明人:
HOWBERT JAMES JEFFRY,HERSHBERG ROBERT,BURGESS LAURENCE E.,DOHERTY GEORGE A.,EARY CHARLES TODD,GRONEBERG ROBERT D.,JONES ZACHARY,LYSSIKATOS JOSEPH P.,YANG HONG WOON,GRONEBERG RO
申请号：
PL12733896
公开号：
PL2663555T3
申请日:
2012.01.12
申请国别(地区):
PL
年份:
2017
代理人:
摘要：
Provided are compounds of formula (II) useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compounds have use in treating or preventing disease, including cancer, autoimmune disease, fibrotic disease, cardiovascular disease, infectious disease, inflammatory disorder, graft rejection, or graft-versus-host disease.
